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A B S T R A C T 
Background: Cervical and breast cancers are the two top leading cases of female 
cancer in Indonesia. Nowadays, many survivors with various degree of cancer-related 
fatigue (CRF) were found in the community context. This study aimed to compare and 
analyse the differences of CRF intensity in cervical cancer survivors (CCS) and breast 
cancer survivors (BCS) generally, and in each stage of cancer survivorship, specifically. 
Methods: This cross-sectional study involved 47 CCS and 55 BCS in the district of 
Rangkah, Gading, and Pacar Keling, Surabaya, Indonesia (n=102). Instrument of Fatigue 
Symptom Inventory (FSI) was used for data collection. Descriptive statistic, 
independent sample t-test, and one way ANOVA test were used for data analysis 
(α<.05). 
 
Results: Most respondents were short term survivors (43.14%) with mild CRF (66.67%) 
in both cases. Higher intensity of CRF was found in CCS compared to BCS. Worst CRF 
was found more in acute and short term survivorship in BCS compared to more in long 
term survivorship in CCS. There was no significant difference of CRF found between CCS 
and BCS (p=.63), and CRF was not significantly different between each stage of cancer 
survivorship in both cases (p=.883 and p=.117 for CCS and BCS respectively), but CRF 
intensity in the worst and lightest time possible was significantly different between CCS 
and BCS (p=.000). 
 
Conclusions: There was no significant difference of CRF between cases and stages of 
survivorship in CCS and BCS, but CRF intensity in the worst and lightest time possible 
was significantly different between those groups. 
 
 
INTRODUCTION 
 
Cancer is defined as a disease in which certain genes 
that control the process of cell regeneration in the 
human body become damaged and led the cells to grow 
abnormally (1). A study in 187 countries from 1980 until 
2010 was conducted to analyze the epidemiology of 
cervical and breast cancer incidence and mortality 
worldwide. Global breast cancer incidence increased 
from 641,000 (95% uncertainty intervals 610,000–
750,000) cases in 1980 to 1,643,000 (1,421,000–
1,782,000) cases in 2010, with an increasing annual rate 
of 3.1%. Global cervical cancer incidence increased from 
378,000 (256,000–489,000) cases per year in 1980 to 
454,000 (318,000–620,000) cases per year in 2010—
indicating 0.6% annual rate of increase. Breast cancer 
killed 425,000 (359,000–453,000) women in 2010, of 
whom 68,000 (62,000–74,000) were aged 15–49 years 
in developing countries. Cervical cancer death rates 
have been decreasing but the disease still killed 200,000 
(139,000–276,000) women in 2010, of whom 46,000 
(33,000–64,000) were aged 15–49 years in developing 
countries (2).  
Nationally, it can be estimated that the incidence of 
cancer in Indonesia is 0.1% of the population, and more 
than 50% of cancer patients first come to seek for 
medication in advance stages (3). In 2013, the 
prevalence of cancer in Indonesia was 1.4% in which the 
prevalence of breast and cervical cancer was 0.8% and 
0.5%, respectively with the state of Yogyakarta holding 
the 1st position for the highest cancer prevalence (4). In 
2014, breast cancer occupied the 1st position of the 
leading cause of death, followed by cervical cancer in 
the 2nd place (5). In 2017, breast cancer still held the 
1st position as the highest new cases and deaths in 
Indonesian cancer statistics (6). In the period of four 
years, we can see that more women suffered from 
cancer. Cervical and breast cancers have been the top 
two leading cases of female cancer in Indonesia for 
several years until now. These phenomena of female 
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cancers possibly happen because more women reported 
higher psychological stress level than men (7), and 
women frequently use hormonal contraceptives (8), 
such as pills/injection/implant; both are inducing 
cancer, especially breast cancer (8, 9).  
Breast and cervical cancers have emerged as major 
global health challenges and disproportionately lead to 
excess morbidity and mortality in low- and middle-
income countries when compared to high-income 
countries (10). Every year, more than 2 million women 
worldwide are diagnosed with breast or cervical cancer, 
yet where a woman lives, her socioeconomic status and 
agency largely determines whether she will develop one 
of these cancers and will ultimately survive (11). The life 
expectancy of people living with cancer increases 
steadily, making cancer one of the non-communicable 
diseases (NCD) with long term burden that needs long-
term supportive and palliative care. The stage of 
survivorship in cancer categorizes into three, namely: 
acute (< 1 year), short term (1-5 years), and long term 
survivorship (> 5 years) (12). The hybrid model suggests 
that cancer-related stressors and cancer therapies cause 
a decrease in four major areas that are cognitive 
function, nutrition, muscle strength, and sleep quality, 
affecting the ability to adapt to ill conditions (13). The 
prolonged total pain and/or suffering, especially in long-
term cancer survivors, will further adversely affect the 
health-related quality of life (QOL). 
In general, cancer therapy includes surgery, 
chemotherapy, and radiotherapy. A symptom that is 
often experienced by the majority of cancer patients, 
especially those who are undergoing chemotherapy or 
radiation therapy, is cancer-related fatigue (CRF) (14). In 
people living with cancer, changes in the biological, 
psychological, and functional aspects also result in CRF 
(13). The National Comprehensive Cancer Network 
(2015) defines CRF as a distressing, persistent, 
subjective sense of physical, emotional, and/or cognitive 
tiredness or exhaustion related to cancer or cancer 
treatment that is not proportional to recent activity and 
interferes with usual functioning (15). The negative 
impact of CRF can even be felt before the formal 
diagnosis of cancer established, and continues to be 
experienced during the treatment process. CRF has a 
significant impact on health status (16). CRF is 
subjective, which can affect physical and cognitive 
function, psychosocial, and can reduce QOL (17). A prior 
study by Sari (2018) towards 129 cancer survivors (58 
breast cancer, 47 cervical cancer, and 24 other cancer 
survivors) found that CRF influenced QOL significantly 
by 53.60% (p=.000) (18).  
This study aims to compare and analyze the 
differences of CRF intensity in cervical cancer survivors 
(CCS) and breast cancer survivors (BCS) generally, and in 
each stage of cancer survivorship, specifically. Cervical 
cancer and breast cancer have different etiology, 
symptoms, and complications. The longer the women 
live with cervical or breast cancer, the more cancer-
related stressor, and treatments exposed towards them. 
Therefore there is a high possibility that CRF intensity 
will be different not only between cervical and breast 
cancer but also between each stage of cancer 
survivorship within. By knowing the results of this study, 
it will be beneficial for developing a particular 
intervention by targeting CRF factors’ modification 
(possible etiology) and finding suitable management in 
every stage of cancer survivorship in CCS and BCS. 
       
METHODS 
 
This cross-sectional study involved 47 CCS and 55 
BCS in the district of Rangkah, Gading, and Pacarkeling, 
Surabaya, Indonesia. Cancer survivorship was divided 
into 3 categories: 1) acute (< 1 year), 2) short term (1-5 
years), and 3) long term survivorship (> 5 years) [9].  
Inclusion criteria consisted of: 1) being an adult (> 18 
years old); 2) cancer diagnosis has been confirmed; 3) 
regularly home-visited by a palliative volunteer under 
the supervision of Rangkah Public Health Center, 
Surabaya, and; 4) CRF was being one of the cancer 
symptom experienced in the period of one week prior 
to the data collection process. Exclusion criteria were 
rejection on filling out the consent form, very poor 
condition, and consciousness loss or disorientation. 
Total sampling was applied and the sample size of 102 
subjects was obtained. Instrument of Fatigue Symptom 
Inventory (FSI), which was developed by Moffitt Cancer 
Center and University of South Florida (1998), was used 
for data collection (19). Fatigue Symptom Inventory (FSI) 
has 14 items. The score range for each item is 0-10. It 
means total score is between 0-140. CRF was divided 
into 3 categories based on FSI total score: 1) mild 
fatigue (total score 1-47); 2) moderate fatigue (total 
score 48-93); and 3) severe fatigue (total score 94-140). 
These 3 categories were made just to ease the data 
presentation in the result section, but for statistical 
analysis I used the pure total score to be analyzed 
further. 
Data were collected from February until March 
2018. Descriptive statistic, independent sample t-test, 
and one-way analysis of variance (ANOVA) test were 
used for data analysis (α<.05). Ethical clearance was 
issued by the Faculty of Nursing, Universitas Airlangga, 
Surabaya, Indonesia, with certificate number of 681-
KEPK. 
 
RESULTS 
 
Most respondents were Javanese, Islam, married, 
housewife, with monthly income (GDP) less than the 
minimum wage of Surabaya in 2018 (IDR 3,300,000.00).  
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Table 1. Demographic characteristics 
Characteristics 
Cervical Cancer 
(n=47) 
Breast Cancer 
(n=55)  
Frequency (%) Frequency (%) 
Age (years old) 
     < 21  
 
0 (0) 
 
0 (0) 
    21-30  0 (0) 5 (9.09) 
    31-40  
    41-50  
    51-60  
    61-70 
    > 70  
5 (10.64) 
11 (23.40) 
17 (36.17) 
13 (27.66) 
1 (2.13) 
10 (18.18) 
13 (23.64) 
15 (27.27) 
8 (14.54) 
4 (7.27) 
Religion 
   Catholic 
   Christian 
   Islam 
 
0 (0) 
7 (14.89) 
40 (85.11) 
 
1 (1.82) 
10 (18.18) 
44 (80.0) 
Ethnic 
   Javanese 
   Maduranese 
   Chinese 
 
40 (85.11) 
6 (12.76) 
1 (2.13) 
 
54 (98.18) 
0 (0) 
1 (1.82) 
Educational background 
   Primary school 
 
15 (31.91) 
 
11 (20.0) 
   Secondary school 
   High school 
   Diploma/Bachelor degree 
   Uneducated  
14 (29.79) 
13 (27.66) 
2 (4.25) 
3 (6.38) 
5 (9.09) 
24 (43.64) 
14 (25.45) 
1 (1.82) 
Marital status 
   Single 
   Married 
   Widow 
   Divorce 
 
3 (6.38) 
39 (82.98) 
4 (8.51) 
1 (2.13) 
 
6 (10.91) 
35 (63.64) 
14 (25.45) 
0 (0) 
Living at home with
a
 
    Spouse 
    Children 
    Alone 
    Parents 
    Sibling 
Occupational status 
    Full-timer 
    Part-timer 
    Retired  
    Housewife 
    Seeking  job 
    Unemployed  
 
39 (82.98) 
17 (36.17) 
3 (6.38) 
0 (0) 
0 (0) 
 
2 (4.25) 
3 (6.38) 
0 (0) 
40 (85.11) 
0 (0) 
2 (4.25) 
 
29 (52.73) 
34 (61.82) 
2 (3.64) 
9 (16.36) 
2 (3.64) 
 
9 (16.36) 
2 (3.64) 
4 (7.27) 
36 (65.45) 
1 (1.82) 
3 (5.45) 
Monthly income  
    < minimum wage 
    Minimum wage
b
 
    > Minimum wage 
    No income  
 
34 (72.34) 
8 (17.02) 
3 (6.38) 
2 (4.25) 
 
32 (58.18) 
13 (23.64) 
6 (10.91) 
3 (5.45) 
a
Respondents may choose more than 1 answer 
b
IDR 5 million 
 
Educational background, occupational status, and 
monthly income were better in the group of BCS. The 
majority was aged 51-60 years old in both cases, but 
CCSs tend to be older than BCSs. Cervical cancer 
survivors (CSS) who were married mostly had no child, 
but most BCS live with their spouse and children. More 
single women were found to have breast cancer in this 
study. Table 1 shows the demography characteristic of 
study respondents in details. 
The majority of respondents in both groups were 
diagnosed before 2014 (more than five years ago). Most 
breast cancer survivors undertook surgery only, for both 
curative and palliative purposes. In the other hand, 
most cervical cancer survivors undertook a more 
complex regiment, which is a combination of surgery 
and chemo-radiotherapy. Table 2 shows the time of first 
diagnosis and the therapeutic regiments for both cases 
in details. 
Most respondents were short term survivors 
(43.14% in total) with mild CRF (66.67% in total). More 
acute survivors were found in breast cancer cases 
(32.73%). Mild CRF was found in the majority for all 
stages of cancer survivorship in both cases, but more 
severe CRF was found in short term survivors in the case 
of cervical cancer (8.7%) compared to other stages and 
cases. As for moderate CRF, it was found more in short 
and long term survivors in the case of cervical cancer, 
compared to more in acute and short term survivors in 
the case of breast cancer. Table 3 shows the CRF level in 
all stages of cancer survivorship for both cases in details. 
Descriptive statistic results showed that CRF mean 
and standard deviation (SD) in the CCS group were 
39.98 and 24.78 respectively, while for BCS group the 
CRF mean and SD were 37.44 and 27.75 respectively. 
This indicates that more severe CRF was found in CCSs 
and data was more homogenous compared to BCS 
because of lower SD. 
 
Table 2. Primary data 
Characteristics 
Cervical 
Cancer (n=47) 
Breast Cancer  
(n=55)  
Frequency (%) Frequency (%) 
Firstly diagnosed 
  2018 
  2017 
  2016 
  2015 
  2014 
  < 2014 
 
0 (0) 
7 (14.89) 
12 (25.53) 
5 (8.62) 
5 (8.62) 
18 (38.30) 
 
4 (7.72) 
14 (25.45) 
7 (12.73) 
10 (18.18) 
2 (3.64) 
18 (32.73) 
Type of therapy 
  Surgery  
  Chemotherapy 
  Surgery + chemotherapy 
  Surgery + radiotherapy 
  Chemotherapy +   
    radiotherapy 
  Surgery + chemotherapy + 
    radiotherapy 
  Surgery + chemotherapy +  
    radiotherapy + analgesic  
  Surgery + chemotherapy +  
    radiotherapy + medicine 
  Surgery + chemotherapy +  
    oral medicine  
  Oral medicine (various) 
  Untreated 
 
5 (8.62) 
13 (27.66) 
2 (4.25) 
0 (0) 
7 (14.89) 
 
17 (36.17) 
 
1 (2.13) 
 
1 (2.13) 
 
0 (0) 
 
0 (0) 
1 (2.13) 
 
24 (43.64) 
8 (14.55) 
10 (18.18) 
1 (1.82) 
1 (1.82) 
 
5 (9.09) 
 
0 (0) 
 
0 (0) 
 
1 (1.82) 
 
4 (7.27) 
1 (1.82) 
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Table 3. Comparison of CRF in all stages of survivorship 
between CCS and BCS 
 
Case Survivorship 
Stage 
CRF Level* Frequency 
(%) 
Cervical 
cancer 
(n=47) 
Acute  
(n=7) 
Mild 6 (12.77) 
Moderate 1 (2.13) 
Severe 0 (0) 
Short term  
(n=23) 
Mild 17 (36.17) 
Moderate 4 (8.51) 
Severe 2 (4.26) 
Long term  
(n=17) 
Mild 12 (25.53) 
Moderate 5 (10.64) 
Severe 0 (0) 
Breast 
cancer 
(n=55) 
Acute  
(n=18) 
Mild 10 (18.18) 
Moderate 7 (12.73) 
Severe 1 (1.82) 
Short term  
(n=21) 
Mild 11 (20.0) 
Moderate 9 (16.36) 
Severe 1 (1.82) 
Long term  
(n=16) 
Mild 12 (21.82) 
Moderate 3 (5.45) 
Severe 1 (1.82) 
*Category was made to ease the data presentation, and not 
for statistical analysis purposes 
 
Independent sample t-test showed that there was 
no significant difference of CRF between CCS and BCS (p 
= .63), but deeper analysis towards each item of FSI 
showed a significant difference in CRF intensity, 
especially in item 1 and 2 about the worst and lightest 
time possible of daily CRF (@ p = .000). Most BCS 
reported milder CRF even in the worst time possible 
compared to CCS, while most CCS reported moderate 
CRF even in the lightest time possible compared to BCS. 
More severe CRF intensity was found more in CCS than 
BCS; this confirmed the results of descriptive statistic 
above. Table 4 and 5 shows the CRF intensity between 
CCS and BCS in details. 
One way ANOVA test results showed that CRF was 
not significantly different between each stage of cancer 
survivorship in both cases (p = .883 and p = .117 for CCS 
and BCS respectively), and deeper analysis also showed 
that there was no significant difference in each item of 
FSI in both cases (p > α for all items of FSI). Table 6 and 
7 shows the result of one way ANOVA in details. 
 
Table 4. Comparison of CRF intensity between BCS and CCS 
 
Cases mean SD CI95% t F p-value 
Breast 
cancer 
(n=55) 
37.44 27.74 
-7.87 
– 
12.96 
.489 
2.471 p = .63 
Cervical 
cancer 
(n=47) 
39.98 24.78 .484 
 
Table 5. Comparison of CRF intensity in the worst and lightest 
time of daily CRF between CCS and BCS 
 
Item of FSI Case CRF 
Intensity* 
Frequency 
(%) 
Q1: Rate your level 
of fatigue on the 
day you felt most 
fatigued during the 
past week! 
Cervical 
cancer 
Mild  8 (17.02) 
Moderate  18 (38.30) 
Severe  21 (44.68) 
Breast 
cancer  
Mild  26 (47.27) 
Moderate  21 (38.18) 
Severe  8 (14.55) 
Q2: Rate your level 
of fatigue on the 
day you felt least 
fatigued during the 
past week! 
Cervical 
cancer 
Mild  20 (42.55) 
Moderate  23 (48.94) 
Severe  4 (8.51) 
Breast 
cancer  
Mild  42 (76.36) 
Moderate  10 (18.18) 
Severe   3 (5.45) 
*Category was made to ease the data presentation, and not 
for statistical analysis purposes 
Table 6. Comparison of CRF intensity between each stage of 
cancer survivorship in BCS based on FSI scores 
 
Survivor 
Stages 
mean SD CI95% F p-value 
Acute 
(n=18) 
37.44 27.74 
-11.09 
– 
25.93 
2.234 p = .117 
Short-term 
(n=21) 
39.98 24.78 
Long-term 
(n=16) 
25.38 17.47 
Table 7. Comparison of CRF intensity between each stage of 
cancer survivorship in CCS based on FSI scores 
 
Survivor 
Stages 
mean SD CI95% F p-value 
Acute (n=7) 35.57 14.52 
-21.74 
– 
16.62 
.125 p = .883 
Short-term 
(n=23) 
40.78 25.91 
Long-term 
(n=17) 
40.71 27.44 
 
DISCUSSION 
 
Cancer is a large group of diseases characterized by 
uncontrolled growth of abnormal cells that are able to 
invade other tissues and spread to other parts of the 
body. Surviving cancer often requires treatment with 
multimodal therapy that can last many months or years:  
surgery, radiation therapy, chemotherapy, hormone or 
endocrine therapy, biologic or immunotherapy, targeted 
therapies, and stem cell transplantation (20).  Results 
showed that most respondents were short term 
survivors (43.14% in total). Proportion of survivorship in 
CCS (n=47) compared to BCS (n=55) for acute : short-
term : long-term survivorship was 7 : 23 : 17 compared 
to 18 : 21 : 16 respectively. This indicates that the 
N I  P U T U  W U L A N  P U R N A M A  S A R I    | 9 
 
 
P-ISSN: 1978-3744 E-ISSN: 2355-6811 
survival rate of breast and cervical cancer is particularly 
long, which makes both types of cancer a chronic 
disease with high burden that requires long-term and 
supportive/palliative care. More acute survivors were 
found in the case of breast cancer (32.73%), but this 
possibly happens because more BCS participated in this 
study compared to CCS. This result indicates that the 
stage of survivorship found in the community setting of 
Surabaya between CCS and BCS was similar. There was 
no significant disparity found between CCS and BCS 
regarding survivorship. Nowadays, advances have 
occurred in the area of female cancer survivorship, but 
sometimes challenges and gaps in relevant information 
remain.   
A study towards 379 BCS about their perspectives 
regarding their experiences of the survivorship 
continuum from diagnosis through 30 months post-
treatment showed that social support and positive 
worldviews were the themes with the most significant 
impact on long-term breast cancer survivorship 
experiences. Breast Cancer Survivors (BCS) expressed a 
need to advance their health care literacy in order to 
share ownership of breast cancer and lymphedema 
treatment decisions. Since breast cancer is an immune-
mediated disease, long-term survivorship planning 
should address psychosocial factors that influence the 
long-term psychological distress associated with 
immune dysfunction (21). Obesity has been associated 
with breast cancer recurrence and poorer survival (22). 
A similar study in the case of cervical cancer is not found 
yet.  
CRF is a distressing, persistent, subjective sense of 
physical, emotional, and/or cognitive tiredness or 
exhaustion related to cancer or cancer treatment that is 
not proportional to recent activity and interferes with 
usual functioning (15). Cancer-related fatigue (CRF) is a 
highly prevalent symptom experienced by most cancer 
patients during, and often for considerable periods 
after, treatment (17). There are three categories of CRF 
as proposed by the Canadian Association of 
Psychosocial Oncology, namely: mild, moderate, and 
severe CRF, with different indicators and management 
(23). Mild CRF is characterized by minimal fatigue 
symptoms, and able to carry out activities of daily living 
[self-care, homemaking, work, leisure]. Moderate CRF is 
characterized by symptoms that cause moderate to high 
levels of distress, a decreasing activity of daily living 
(ADLs), and some impairment in physical functioning. 
Severe CRF is characterized by significant fatigue on a 
daily basis, excessive need to sit or sleep, severe 
impairment of activity of daily living, sudden onset of 
fatigue and/or shortness of breath at rest, rapid heart 
rate and/or blood loss.  
Screening for CRF is needed at the entry to health 
care system, periodically throughout treatment, post-
treatment follow-up and advanced disease. CRF 
guidelines were proposed by Howell, et al. (2015) and 
were recommended by the Canadian Association of 
Psychosocial Oncology (23). Cancer-related fatigue (CRF) 
prevention and supportive care interventions for all 
cancer patients and caregivers include: 1) education 
about the difference between normal and CRF, 
treatment-related fatigue patterns/fluctuations, 
persistence of CRF post-treatment, causes (contributing 
factors) of CRF, consequences of CRF, benefits of 
physical activity during and post-treatment, and signs 
and symptoms of worsening CRF to report to health 
care professionals; 2) counseling about how to balance 
energy conservation with activity, and use of distraction 
such as games, music, reading, and socializing; 3) 
encouragement for patients to use a treatment log or 
diary to monitor levels and patterns of CRF, to help 
ascertain peak energy periods, and to help with 
planning activities.  
Results showed that most respondents experienced 
mild CRF (66.67% in total). Mild CRF was found in the 
majority of all stages of cancer survivorship in both 
cases. Generally, higher CRF intensity was found in CCS 
compared to BCS with mean of 39.98 compared to 
37.44 respectively. Higher intensity of CRF was found in 
CCS, but there was no significant difference in CRF 
found between CCS and BCS (p = .63). One way ANOVA 
test results showed that CRF was not significantly 
different between each stage of cancer survivorship in 
both cases (p = .883 and p = .117 for CCS and BCS 
respectively). 
There was 60% of BCS with mild CRF found in this 
study. Mild CRF was found in the majority in all 
survivorship stages in BCS. In the case of breast cancer, 
the experience of CRF is one of the most common and 
debilitating symptoms of breast cancer treatment. A 
qualitative study towards 10 BCS showed that every 
woman had a very individualized CRF experience, yet, 
there were also some perspective similarities. Living 
with CRF resulted in fear and uncertainty in BCS; 
however, with the passage of time, most BCS discovered 
positive aspects of their experience (24). A similar study 
in the case of cervical cancer was not found. There were 
74.47% CCS with mild CRF found in this study. Mild CRF 
was found in the majority in all survivorship stage in 
CCS. Although fewer CCS participated in this study, we 
found more patients with mild CRF in CCS compared to 
BCS which was only 60%. 
Moderate CRF was found more in long term 
survivors in the case of cervical cancer compared to 
more in acute and short term survivors in the case of 
breast cancer. In the case of cervical cancer, a higher 
intensity of CRF was found in the later stage of 
survivorship. This possibly happens due to therapy 
complexity and malnutrition. Results showed that most 
CCS undertook a more complex regiment compared to 
BCS, which is a combination of surgery and chemo-
radiotherapy (36.17%). Post-chemotherapy, cancer 
patients may experience malnutrition; even before 
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treatment they often have metabolic disorders (25). 
Malnutrition and weight loss in cancer patients are 
caused by several mechanisms of cancer and host 
response to tumors and anti-cancer therapy. In addition, 
lack of energy, protein and/or other nutrients in 
malnourished patients can cause opposite effects on 
body tissue formation, body composition, body 
function, and clinical outcome, especially CRF. 
Malnutrition is associated with decreased survival rate, 
therapeutic response, and QOL in cancer patients (16).  
Severe CRF was found more in short term survivors 
of CCS (8.7%) compared to other stages and BCS. There 
are some factors related to the severity of CRF in cancer 
patients. Female gender, being unemployed, higher 
cancer stage (III-IV) at diagnosis, receiving active 
treatment at the time of study participation, being 
treated with palliative intent, having had radiotherapy, 
higher fear of recurrence or progression, and higher 
psychological distress was significantly correlated with 
CRF severity (26). A study towards 139 women living 
with breast cancer in communities of Surabaya showed 
that those with breast cancer mostly aged middle-up 
adulthood compared to older age in cervical cancer, and 
the number of early adults and adolescent female with 
breast or cervical cancer cannot be ignored (7.17% in 
total) (27). Therefore, detection and management of 
severe CRF in cancer patients, especially in late 
adolescence or young adulthood, is really important 
because it could affect QOL significantly (26).   
A previous study towards African-American women 
with breast cancer showed that common side effects, 
including CRF, loss of strength, difficulty sleeping, and 
sexual dysfunction, last for long periods after cancer 
treatment (22). This study found that in the case of 
breast cancer, higher intensity of CRF was found more in 
earlier survivorship stage compared to CCS. A significant 
difference was found in CRF intensity item 1 and 2 in the 
worst and lightest time possible (@ p = .000). Most BCS 
reported milder CRF even in the worst time possible 
compared to CCS, while most CCS reported moderate 
CRF even in the lightest time possible compared to BCS. 
Therefore, these study results challenge the findings of 
this previous study, especially in the field of CRF if 
compared to CCS. In BCS, higher intensity of CRF which 
was found more in earlier survivorship stage possibly 
due to impaired psychological wellbeing. Cancer-Related 
Fatigue (CRF) is a subjective experience which can be 
influenced by psychological state (17). Prior study 
results found more severe clinical manifestations of 
cancer in CCS compared to BCS, including CRF, but 
surprisingly CCS expressed better health status than BCS 
(28). This finding indicates that CCS implemented a 
more adaptive coping strategy in facing the disease, 
especially in the earlier stage of survivorship. Even so, 
physical wellbeing was found better in BCS. This may be 
influenced by various factors involving disease 
mechanism, host response towards tumor/cancer, and 
the side effect of anti-cancer therapy (28). 
Prior study results showed that there was no 
significant difference in therapy between cases (p = 
.076); although chemotherapy has no significant effect 
on CRF in both cases (p=.060 and p=.784 for CCS and 
BCS respectively) but there was a significant difference 
of CRF found between CCS and BCS who received 
chemotherapy as one of their cancer regiments (p = 
.009) (29). This study results showed that CRF did not 
differ significantly between cases and between stages of 
survivorship. However, the intensity of CRF was 
determined by cases in this study context. Therefore, 
the type of cancer and chemotherapy are the two 
factors that determine CRF intensity in the case of 
female cancer. 
 
CONCLUSION 
 
There was no significant difference of CRF between 
CCS and BCS, but a significant difference of CRF intensity 
was found in the worst and lightest time possible 
between cases. There was no significant difference of 
CRF found between stages of cancer survivorship in 
both cases. Higher intensity of CRF was found in CCS 
compared to BCS. Worst CRF was found more in acute 
and short term survivorship in BCS compared to more in 
long term survivorship in CCS. CRF intensity is 
determined by cases in women living with cancer. 
 
DECLARATIONS 
 
Ethical approval 
This study protocol has been reviewed for ethical 
purposes. Ethical clearance was issued by the Faculty of 
Nursing, Universitas Airlangga, Surabaya, Indonesia, 
with certificate number of 681-KEPK. Prior to data 
collection, all respondents got an explanation about 
study benefits and potential risk and other technical 
instructions. All respondents had signed the consent 
forms and expressed the agreement to participate in 
this study. 
 
Competing of Interest 
I declare that I do not have any competing interest, 
especially with the study funder. 
 
Acknowledgement 
This study was funded by the Center of Food and 
Nutritional Research, Institute of Research and 
Community Service, Widya Mandala Catholic University 
Surabaya, by Grant number:  077a/WM01.5.2/N/2018. 
This publication was supported by the Faculty of 
Nursing, Widya Mandala Catholic University Surabaya. 
 
N I  P U T U  W U L A N  P U R N A M A  S A R I    | 11 
 
 
P-ISSN: 1978-3744 E-ISSN: 2355-6811 
REFERENCES 
1. Kaplan M. The Hispanic outlook in higher education. 
Paramus. 2008; 18(17): 42-44. 
2. Forounzafar MH, Foreman KJ, Delossantos AM, 
Lozano R, Lopez AD, Murray CJL, Naghavi M. Breast 
and cervical cancer in 187 countries between 1980 
and 2010: a systematic analysis,. The Lancet. 2011; 
378(9801): 1461-1484. 
3. Tejawinata S. Surabaya, The City of Palliative: Its 
Image and Charm (in Bahasa Indonesia). 2012. 
Surabaya: Airlangga University Press. 
4. Irawan KI. Cancer detection (in Bahasa Indonesia). 
Kompas. Retrieved from: 
https://www.pressreader.com/indonesia/kompas/2
0180312/282475709343993 
5. World Health Organization (WHO). Cancer Country 
Profiles (2014). 2015. Retrieved from: 
https://www.who.int/cancer/country-profiles/en/ 
6. Arafah ABR, Notobroto HB. Factors associated with 
housewives behavior in doing breast self-
assessment (in Bahasa Indonesia). The Indonesian 
Journal of Public Health. 2017; 12(2): 143-153.  
7. American Psychological Association. Gender and 
stress. 2010. Retrieved from: 
https://www.apa.org/news/press/releases/stress/2
010/gender-stress.aspx 
8. Westhoff CL, Pike MC. Hormonal contraception and 
breast cancer. Am J Obstet Gynecol. 2018; 219(2): 
169.e1-169.e4. 
9. Chiriac V-F, Baban A, Dumitrascu DL. Psychological 
stress and breast cancer incidence: a systematic 
review. 2018; 91(1): 18-26. 
10. Demment MM, Peters K, Dykens JA, Dozier A, 
Nawaz H, McIntosh S, Smith JS, Sy A, Irwin T, Fogg 
TT, Khaliq M, Blumenfeld R, Massoudi M, De Ver 
Dye T. Developing the evidence base to inform best 
practice: a scoping study of breast and cervical 
cancer reviews in low- and middle-income 
countries. PLoS ONE. 2015; 10(9): e0134618.  
11. Ginsburg O, Bray, F, Coleman MP, Vanderpuve V, 
Eniu A, Kotha SR, Sarker M, Huong TT, Allemani, C, 
Dvaladze A, Gralow J, Yeates K, Taylor C, Oomman 
N, Khrishnan S, Sullivan R, Kombe D, Blas MM, 
Parham G, Kassami N, Conteh L. The global burden 
of women’s cancers: a grand challenge in global 
health. The Lancet Series: Health, Equity, and 
Women’s Cancers 2. 2017; 389: 847-860. 
12. Campo RA, Lenjek KL, Gaylord-scott N, Faurot KR, 
Smith S, Asher G, Porterfield D, Gaylord SA. 
Weathering the seasons of cancer survivorship: 
mind-body therapy use and reported reasons and 
outcomes by stages of cancer survivorship. 
Supportive Care in Cancer Survivorship. 2016; 24(9): 
3783-3791. 
13. Mitchell S. Cancer-related fatigue: state of the 
science. Am Acad Phys Med Rehabil R. 2010; 5: 609-
617.  
14. Borneman T. Assessment and management of 
cancer-related fatigue. Journal of Hospice & 
Palliative Nursing. 2013; 15(2): 77-86.   
15. The National Comprehensive Cancer Network. 
Cancer-related fatigue-version 2.2015. Natl Compr 
Canc Netw. 2015; 13: 1012-1039.  
16. Andreoli A, de Lorenzo A, Cadeddu F, Grande M. 
New trends in nutritional status assessment of 
cancer patients. European Review for Medical and 
Pharmacological Sciences. 2011; 15: 469-480.  
17. Jean-Pierre P, Figueora-Moseley CD, Kohli S, Fiscella 
K, Palesh OG, Morrow GR. Assessment of cancer-
related fatigue: implications for clinical diagnosis 
and treatment. The Oncologist. 2007; 12(12): 11-21.   
18. Sari NPWP. The influence of nutritional status and 
cancer-related fatigue (CRF) on quality of life in 
cancer survivors. Proceeding of The First 
International Conference on Health Care and 
Management. 2018. Retrieved from: http://stikep-
ppnijabar.ac.id/conference/index.php/ichm/ichm20
18/paper/view/14/10 
19. Jacobsen PB. Assessment of fatigue in cancer 
patients. Journal of The National Cancer Institute 
Monographs. 2004. 32: 
10.1093/jncimonographs/lgh010.  
20. Courneya KS, Rogers LQ, Campbell KL, Vallance JK, 
Friedenreich CM. Top 10 research questions related 
to physical activity and cancer survivorship. 
Research Quarterly for Exercise and Sport. 2015; 
86: 107-116.  
21. Hulett JM, Armer JM, Stewart BR, Wanchai A. 
Perspectives of the breast cancer survivorship 
continuum: diagnosis through 30 months post-
treatment. J Pers Med. 2015; 5(2): 174-190.  
22. Coughlin SS, Yoo W, Whitehead MS, Smith SA. 
Advancing breast cancer survivorship among 
African-American women. Breast Cancer Res Treat. 
2015; 153: 253-261.  
23. Howell D, Keller-Olaman S, Oliver TK, Hack TF, 
Broadfield L, Biggs K, Chung J, Gravelle D, Green E, 
Hamel M, Harth T, Johnston P, McLeod D, Swinton 
N, Syme A, Olson K. A pan-Canadian practice 
guideline and algorithm: screening, assessment, 
and supportive care of adults with cancer-related 
fatigue. Curr Oncol. 2013; 20(3): e233-46. 
24. Anglehart ML. Moving out of the shadow of cancer 
while living with cancer-related fatigue: identifying 
the perspective of breast cancer survivors. Thesis. 
2006. Wellington, Canada: The University of New 
Brunswick.  
25. Trijayanti E, Probosari E. Correlation between food 
intake and nutritional status in post-chemotherapy 
cervical cancer patients (in Bahasa Indonesia). 
Jurnal Kedokteran Diponegoro. 2016; 5(4): 751-760.  
12 |   Fatigue Intensity in Breast and Cervical Cancer Survivorsl 
 
 
 
www.indonesianjournalofcancer.or.id 
26. Poort H, Kaal SEJ, Knoop H, Jansen R, Prins JB, 
Manten-Horst E, Servaes P, Husson O, van der Graaf 
WTA. Prevalence and impact of severe fatigue in 
adolescent and young adult cancer patients in 
comparison with population-based controls. 
Support Care Cancer. 2017; 25: 2911-2918.  
27. Sari NPWP. Women living with breast and cervical 
cancer in the community: the face of Surabaya 
nowadays. Indonesian Journal of Cancer. 2018; 
12(4): 116-122. 
28. Sari NPWP. Physical wellbeing in cervical and breast 
cancer survivors: a cross-sectional study in 
Surabaya, Indonesia. Indonesian Journal of Cancer. 
2018; 12(3): 80-87. 
29. Sari NPWP. Chemotherapy-Induced Cancer-Related 
Fatigue in Cervical and Breast Cancer Survivors. 
Proceedings of Researchfora International 
Conference. 2018. India: IRAJ Research Forum, 
Institute of Research and Journals. 
 
 
 
